In July 2024, 45-year-old Park Joo-hye received a stage 4 cholangiocarcinoma diagnosis alongside a terminal prognosis of roughly six months to live. Bile duct cancer rarely presents early symptoms, making advanced-stage detection challenging and typically associated with poor survival rates. However, by April 2025, medical evaluations confirmed a complete remission, with all detectable cancer cells eradicated after treatment at a specialized facility in Seoul.
Initial Diagnosis and Symptoms
Park visited a medical center on July 9, 2024, following persistent abdominal discomfort. Expecting routine findings after a prior health screening three months earlier—which had excluded liver, bile duct, and pancreatic checks—she instead learned from her physician that she exhibited signs of advanced pancreatic cancer, a diagnosis later reclassified as cholangiocarcinoma. The malignancy had grown to over 7.5 centimeters, pressing against her duodenum and generating a distinct gurgling sound when she lay on her left side. Despite lacking dramatic weight loss or abnormal tumor marker levels such as CEA, she suffered from severe, twisting abdominal pain and back stiffness in the weeks leading up to her formal tissue biopsy.
Treatment and Complete Remission
Following her biopsy, Park sought care from a pancreatic cancer specialist in Seoul, traveling regularly from Ulsan to manage her regimen. Although options for advanced pancreatic and bile duct cancers remain limited to a narrow selection of chemotherapeutic agents, the chosen regimen successfully reduced the tumor mass. Ten months after her initial terminal diagnosis, hospital evaluations declared her in complete remission, an outcome her medical team noted as highly unusual for the stage and type of disease.
Related reading